Lung Health

Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.

Chicago magazine list includes pulmonology, allergy and immunology specialists

"It's the only way we have to catch lung cancer early"

A severe case of COVID-19 leads to a life-saving lung cancer diagnosis

Thomas Magliano went to a screening on a whim. RUSH caught his cancer early.  

Three-star rating distinguishes RUSH cardiac and thoracic surgery programs as among the best in the nation

Rush physician Jennifer Earvolino, MD, explains how screenings work, who should get them

Eligibility for cancer screening can be a 'wake-up call'

A Rush screening manager on overcoming the stigma to help catch lung cancer early

Regaining strength and hope after lung cancer